Jun Deng
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Immune cells in cancer
Papers in
-
- Cancer-related gene regulation 5
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Cancer-related Molecular Pathways 4
- Co-authors
- Jianping Xiong (18 shared papers)Yangyang Yao (8 shared papers)Xiaojun Xiang (7 shared papers)Shanshan Huang (7 shared papers)Yanting Liu (1 shared paper)Hui Guo (4 shared papers)Zhengwei Mao (1 shared paper)Haibo Wang (1 shared paper)
- Journals
- Molecular Cancer (2 papers)World Journal of Gastroenterology (1 paper)Cell Death Discovery (1 paper)Oncology Reports (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Jun Deng
29 papers receiving 452 citations
Jun Deng's Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 178
- Immunology 122
- Cancer Research 82
- Molecular Biology 230
- Cell Biology 50
Countries citing papers authored by Jun Deng
This map shows the geographic impact of Jun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Deng more than expected).
Fields of papers citing papers by Jun Deng
This network shows the impact of papers produced by Jun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Deng. The network helps show where Jun Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 77 | |
| 2 | Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy Hit paper breakdown → | 2024 | 68 |
| 3 | 2023 | 59 | |
| 4 | 2022 | 32 | |
| 5 | 2021 | 26 | |
| 6 | 2018 | 22 | |
| 7 | 2023 | 19 | |
| 8 | 2019 | 19 | |
| 9 | 2020 | 16 | |
| 10 | 2017 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2024 | 12 | |
| 13 | 2022 | 12 | |
| 14 | 2024 | 10 | |
| 15 | 2024 | 10 | |
| 16 | 2023 | 9 | |
| 17 | 2020 | 7 | |
| 18 | Hdc-expressing myeloid-derived suppressor cells promote basal-like transition and metastasis of breast cancer. | 2020 | 7 |
| 19 | 2024 | 6 | |
| 20 | 2023 | 4 |
About Jun Deng
Jun Deng is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Immunology, having authored 30 papers that have together received 460 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Hippo pathway signaling and YAP/TAZ (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer-related gene regulation (5 papers), Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Advanced Combustion Engine Technologies (3 papers). The work is most often cited by research in Oncology (178 citations), Immunology (122 citations), Cancer Research (82 citations), Molecular Biology (230 citations) and Cell Biology (50 citations). Jun Deng has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Jianping Xiong, Yangyang Yao, Xiaojun Xiang, Shanshan Huang, Yanting Liu, Hui Guo, Zhengwei Mao, Haibo Wang, Xuntao Yin and Wei Chen. Their work appears in journals such as Molecular Cancer, World Journal of Gastroenterology, Cell Death Discovery, Oncology Reports and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.